Richard Rosen, MD
This is a Phase II multicenter, randomized, double-masked, placebo-controlled, dose-comparison study of the safety and efficacy of fenretinide in the treatment of Geographic Atrophy in subjects with AMD. Subjects will be given PreserVision® Lutein Soft Gels Eye Vitamins, without beta-carotene, to take throughout the study.
Study results are currently being analyzed. Please visit this webpage next month for the study update.
For more information: